Thrombospondin-1 Regulates Vascular Tone
Thrombospondin-1 调节血管张力
基本信息
- 批准号:7911886
- 负责人:
- 金额:$ 21.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-17 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAcuteAdhesionsAngiogenesis InhibitorsAreaArteriesBindingBloodBlood PlateletsBlood VesselsBlood flowBrain Hypoxia-IschemiaCD36 geneCD47 geneCell Surface ReceptorsCell surfaceCellsContractile ProteinsCyclic GMPDataElectron Spin Resonance SpectroscopyEndothelial CellsExtracellular MatrixGasesGrowthHealthIn VitroLigationMalignant NeoplasmsMeasuresMuscle relaxation phaseMyosin Light ChainsNecrosisNitric OxideOxygenPerfusionPhosphorylationPlayRegulationRelaxationReportingResearch PersonnelRoleSmooth MuscleSmooth Muscle MyocytesSoft Tissue NeoplasmsSoluble Guanylate CyclaseStressStructural ProteinTherapeutic AgentsThrombospondin 1TissuesTransgenic MiceTumor TissueVascular blood supplyVasodilationbasein vivoinhibitor/antagonistmigrationprogramsreceptorresponsesoft tissue
项目摘要
DESCRIPTION (provided by applicant): Blood vessels, as conduits for blood flow, control blood supply to a particular tissue area through alterations in their size. Such changes in vessel size are regulated by vascular smooth muscle cells (VSMC) which form a part of the wall of most blood vessels. Alterations in the contractility of VSMC directly change the size of blood vessels and can increase or decrease blood flow to tissues. Nitric oxide (NO) is a bioactive gas with wide ranging effects in the body. NO has been identified as a locally important regulator of VSMC contractility. These effects require stimulation of soluble guanylyl cyclase (sGC) by NO and result in rapid relaxation of VSMC. Thrombospondin-1 (TSP1) is a major regulator of vascular cell responses first identified as a secretory product from stimulated platelets. TSP1 is an important inhibitor of angiogenesis. We recently reported that TSP1 can block NO-driven effects in VSMC by blocking stimulation of sGC. Low levels of NO induce vascular cells to become hypersensitive to TSP1, with picomolar concentrations being sufficient to inhibit NO-stimulated VSMC cell responses. Based on our preliminary data we hypothesize that TSP1 regulates tissue blood flow and perfusion through control of NO-activated vascular smooth muscle cell contractility. In support of this hypothesis we propose three specific aims: 1) Demonstrate the effect TSP1 has upon contractile proteins in vascular smooth muscle cells. 2) Demonstrate the effects TSP1 has upon NO-driven vasorelaxation of VSMC. 3) Determine the effects of TSP1 on soft tissue perfusion and oxygen under ischemic stress. These studies should provide increased understanding of the role TSP1 plays in regulating vascular responses to nitric oxide and provide direction in developing therapeutic agents tailored to selectively regulate tissue perfusion.
描述(由申请人提供):血管作为血流的导管,通过改变其大小来控制特定组织区域的血液供应。血管尺寸的这种变化由血管平滑肌细胞(VSMC)调节,血管平滑肌细胞形成大多数血管壁的一部分。VSMC收缩性的改变直接改变血管的大小,并可增加或减少流向组织的血流量。一氧化氮(NO)是一种生物活性气体,在体内具有广泛的作用。NO已被确定为VSMC收缩性的局部重要调节剂。这些作用需要通过NO刺激可溶性鸟苷酸环化酶(sGC)并导致VSMC快速松弛。血小板反应蛋白-1(TSP 1)是血管细胞反应的主要调节因子,最初被鉴定为刺激血小板的分泌产物。TSP 1是一种重要的血管生成抑制剂。我们最近报道TSP 1可以通过阻断sGC的刺激来阻断NO驱动的VSMC效应。低水平的NO诱导血管细胞变得对TSP 1过敏,皮摩尔浓度足以抑制NO刺激的VSMC细胞反应。基于我们的初步数据,我们假设,TSP 1通过控制NO激活的血管平滑肌细胞收缩性来调节组织血流和灌注。为了支持这一假设,我们提出了三个具体的目标:1)证明TSP 1对血管平滑肌细胞收缩蛋白的影响。2)证明TSP 1对NO驱动的VSMC血管舒张的影响。3)确定TSP 1对缺血应激下软组织灌注和氧的影响。这些研究应该提供更多的了解TSP 1在调节血管对一氧化氮的反应中所起的作用,并为开发选择性调节组织灌注的治疗药物提供方向。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Amyloid-β inhibits No-cGMP signaling in a CD36- and CD47-dependent manner.
- DOI:10.1371/journal.pone.0015686
- 发表时间:2010-12-22
- 期刊:
- 影响因子:3.7
- 作者:Miller TW;Isenberg JS;Shih HB;Wang Y;Roberts DD
- 通讯作者:Roberts DD
Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation.
- DOI:10.1016/j.niox.2009.05.005
- 发表时间:2009-08
- 期刊:
- 影响因子:0
- 作者:Isenberg JS;Shiva S;Gladwin M
- 通讯作者:Gladwin M
The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47.
- DOI:10.1016/j.matbio.2012.01.005
- 发表时间:2012-04
- 期刊:
- 影响因子:6.9
- 作者:Roberts, David D.;Miller, Thomas W.;Rogers, Natasha M.;Yao, Mingyi;Isenberg, Jeffrey S.
- 通讯作者:Isenberg, Jeffrey S.
Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP.
血小板传播1对血管平滑肌细胞反应的抑制是通过调节CAMP和CGMP发生的。
- DOI:10.1016/j.phrs.2010.10.014
- 发表时间:2011-01
- 期刊:
- 影响因子:9.3
- 作者:Yao, Mingyi;Roberts, David D.;Isenberg, Jeff S.
- 通讯作者:Isenberg, Jeff S.
Molecular regulation of tumor angiogenesis and perfusion via redox signaling.
- DOI:10.1021/cr8005125
- 发表时间:2009-07
- 期刊:
- 影响因子:62.1
- 作者:Miller TW;Isenberg JS;Roberts DD
- 通讯作者:Roberts DD
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey S Isenberg其他文献
Jeffrey S Isenberg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey S Isenberg', 18)}}的其他基金
TSP-1 and ROS: CD47 and SIRP-alpha as Mediators of Vascular Dysfunction
TSP-1 和 ROS:CD47 和 SIRP-α 作为血管功能障碍的介质
- 批准号:
8588484 - 财政年份:2013
- 资助金额:
$ 21.49万 - 项目类别:
TSP-1 and ROS: CD47 and SIRP-alpha as Mediators of Vascular Dysfunction
TSP-1 和 ROS:CD47 和 SIRP-α 作为血管功能障碍的介质
- 批准号:
8720053 - 财政年份:2013
- 资助金额:
$ 21.49万 - 项目类别:
TSP1-CD47 in Promotion of PAH-Associated Vasoconstriction and Vascular Overgrowth
TSP1-CD47 促进 PAH 相关血管收缩和血管过度生长
- 批准号:
8155254 - 财政年份:2011
- 资助金额:
$ 21.49万 - 项目类别:
TSP1-CD47 in Promotion of PAH-Associated Vasoconstriction and Vascular Overgrowth
TSP1-CD47 促进 PAH 相关血管收缩和血管过度生长
- 批准号:
8294522 - 财政年份:2011
- 资助金额:
$ 21.49万 - 项目类别:
TSP1-CD47 in Promotion of PAH-Associated Vasoconstriction and Vascular Overgrowth
TSP1-CD47 促进 PAH 相关血管收缩和血管过度生长
- 批准号:
8513402 - 财政年份:2011
- 资助金额:
$ 21.49万 - 项目类别:
TSP1-CD47 in Promotion of PAH-Associated Vasoconstriction and Vascular Overgrowth
TSP1-CD47 促进 PAH 相关血管收缩和血管过度生长
- 批准号:
8669813 - 财政年份:2011
- 资助金额:
$ 21.49万 - 项目类别:
Thrombospondin-1 Regulates Vascular Tone
Thrombospondin-1 调节血管张力
- 批准号:
7289932 - 财政年份:2008
- 资助金额:
$ 21.49万 - 项目类别:
Thrombospondin-1 Regulates Vascular Tone
Thrombospondin-1 调节血管张力
- 批准号:
7687922 - 财政年份:2008
- 资助金额:
$ 21.49万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 21.49万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 21.49万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 21.49万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 21.49万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 21.49万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 21.49万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 21.49万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 21.49万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 21.49万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 21.49万 - 项目类别:
Operating Grants